Friday, 8 November 2013

Johnson & Johnson to pay $2 billion for false marketing



The penalties announced Monday involve fines and forfeiture to the federal government and several states. The settlement involves the schizophrenia drugs Risperdal and Invega, and the heart failure drug Natrecor, the company and Attorney General Eric Holder said.



Johnson & Johnson and two subsidiaries "lined their pockets at the expense of American taxpayers, patients and the private insurance industry," Holder said.

The penalty amounts to one of the country's largest health care-related settlements, the Justice Department said. Read more
 

No comments:

Post a Comment